A computer-guided quality improvement tool for primary health care: cost-effectiveness analysis based on TORPEDO trial data.
CONCLUSION: Modelled cost-effectiveness analyses provide information that can assist decisions about investing in health care quality improvement interventions. We estimate that HealthTracker could prevent major CVD events for less than $20 000 per event averted.
TRIAL REGISTRATION (TORPEDO): Australian New Zealand Clinical Trials Registry, ACTRN 12611000478910.
PMID: 32594567 [PubMed - as supplied by publisher]
Source: Medical Journal of Australia - Category: General Medicine Tags: Med J Aust Source Type: research
More News: Australia Health | Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Computers | Electronic Health Records (EHR) | General Medicine | Health Management | Heart | New Zealand Health | Wales Health